Health-Care and Societal Costs Associated with Non-Persistence with Subcutaneous TNF-α Inhibitors in the Treatment of Inflammatory Arthritis (IA): A Retrospective Observational Study

OBJECTIVE: A few studies have suggested that patients with inflammatory arthritis (IA) who remain persistent with subcutaneous TNF-α inhibitors (SC-TNFi) incur lower health care costs than patients who discontinue treatment, whereas data on the impact of non-persistence on indirect costs are largely...

Descripción completa

Detalles Bibliográficos
Autores principales: Dalén, Johan, Chitkara, Anushri, Svedbom, Axel, Olofsson, Tor, Puenpatom, Amy, Black, Christopher M., Qureshi, Zaina P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9122890/
https://www.ncbi.nlm.nih.gov/pubmed/34751912
http://dx.doi.org/10.1007/s12325-021-01970-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9122890/
https://www.ncbi.nlm.nih.gov/pubmed/34751912
http://dx.doi.org/10.1007/s12325-021-01970-w

Ejemplares similares